Loading clinical trials...
Loading clinical trials...
A Randomized Phase III Study Comparing Induction Chemotherapy to Daily Low Dose Cisplatin Both Combined With High Dose Radiotherapy Using Concomitant Boost Technique in Patients With Inoperable Non-Small Cell Lung Cancer Stage I, II, and Low Volume Stage III
Conditions
Interventions
cisplatin
gemcitabine hydrochloride
+1 more
Locations
17
Belgium
Algemeen Ziekenhuis Middelheim
Antwerp, Belgium
Hopital de Jolimont
Haine-Saint-Paul, Belgium
CHR de Grenoble - La Tronche
Grenoble, France
Mutterhaus der Borromaerinnen
Trier, Germany
Medisch Centrum Haaglanden
's-Gravenhage (Den Haag, the Hague), Netherlands
Antoni van Leeuwenhoekhuis
Amsterdam, Netherlands
Start Date
February 1, 1999
Primary Completion Date
March 1, 2003
Last Updated
July 18, 2012
NCT05198830
NCT06498635
NCT06305754
NCT05692635
NCT06066138
NCT07485114
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions